Month: February 2025

After months in the pipeline, it looks like the European Health Data Space (EHDS) is finally entering into force later this year. But what does this mean for your organisation? This is the fourth post in our EHDS series. In this post, we focus on the new product regime for electronic health record (EHR) systems, […]

The post EHDS Deep-Dive: EHR systems, wellness apps and medical devices (Part 4) appeared first on Healthcare & Life Sciences Blog.

On 5 November 2024 the Council of the European Union adopted the recast Urban Wastewater Treatment Directive, following the European Parliament’s approval of the text earlier this year.  Of particular relevance to pharmaceutical and cosmetic companies, the recast Directive will introduce new extended producer responsibility (“EPR”) [1] obligations in respect of micropollutants from their products that […]

The post Extended Producer Responsibility for Pharmaceutical and Cosmetics Companies: Adoption of the Recast Urban Wastewater Treatment Directive appeared first on Healthcare & Life Sciences Blog.

On 5 December 2024, the French Government was forced to resign following the vote of non-confidence by the French National Assembly towards the Social Security Financing Bill (“PLFSS“). A new Government was then appointed on 23 December 2024. As a result, 2024 ended without a PLFSS for 2025, leaving the Pharma and MedTech industries in […]

The post The French Political Crisis Leads the Pharmaceutical and Medical Device Industries Towards A Leap Into the Unknown for 2025 appeared first on Healthcare & Life Sciences Blog.